share_log

Barinthus Biotherapeutics | 8-K/A: Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments

SEC ·  May 15 04:08
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.